title: Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids.
abstract: BACKGROUND
  The feasibility of simultaneously infusing glucose and amino acid (AA)-based peritoneal dialysis solutions was tested to determine whether peritoneal dialysis patients could achieve an adequate nonprotein calorie/nitrogen ratio while preventing a marked increase in blood urea nitrogen (BUN), which is usually seen if the AAs are administered without glucose.
  
  
  METHODS
  An automatic peritoneal dialysis cycler was used to infuse glucose and AA solutions (3:1) simultaneously during the night. Eight infusions of 1000 mL m2 of body surface area (BSA), with a 60 minute dwell time, were performed in 10 children on peritoneal dialysis. The dialytic effluent was analyzed at every exchange and totaled at eight hours to evaluate volume, glucose, and AA concentration. Blood samples for plasma, glucose, insulin, and free AA determination were drawn at the beginning of automated peritoneal dialysis (APD) session and at each instillation of peritoneal dialysate.
  
  
  RESULTS
  The mean glucose absorption was 33.7 +/- 10.0% and the AA absorption was 55.2 +/- 13.2% of the infused amount, and the ratio of nonprotein calorie (derived from glucose) to nitrogen (derived from AA) was 115.4:1. The insulin levels returned to normal only three hours after the beginning of APD. The free AA plasma levels were already increased two hours after dinner and remained high for the entire APD treatment because of the continuous absorption of AA from the peritoneum. The BUN levels did not increase despite the supply of AA.
  
  
  CONCLUSIONS
  This APD procedure may improve utilization of AA for protein synthesis, as suggested by the lack of increase of the BUN levels with this regimen.
authors.affiliation: Nephrology Department, G. Gaslini Institute, Genoa, Italy. nefroigg@tin.it
authors.forename: A
authors.initials: A
authors.lastname: Canepa
authors.forename: A
authors.initials: A
authors.lastname: Carrea
authors.forename: S
authors.initials: S
authors.lastname: Menoni
authors.forename: E
authors.initials: E
authors.lastname: Verrina
authors.forename: A
authors.initials: A
authors.lastname: Trivelli
authors.forename: R
authors.initials: R
authors.lastname: Gusmano
authors.forename: F
authors.initials: F
authors.lastname: Perfumo
mesh_terms: D000293:Adolescent; D000596:Amino Acids / Q000008:administration & dosage* / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D015314:Dialysis Solutions; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D009752:Nutritional Status; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D015314:Dialysis Solutions; D005947:Glucose